EGenesis
Cambridge
About EGenesis
EGenesis is a biotechnology company developing solid organ and therapeutic cell transplantation to treat diseases. It offers gene editing and genome engineering platform to develop human-compatible organs, tissues, and cells, aiming to provide an alternative solution to the global organ shortage.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 101 – 250
- Estimated revenue: $10K – $50K
- Total funding: $456.0M
- Funding stage: Late Stage Venture
- Last round: Series D (Sep 2024)
- Website: egenesisbio.com
- Phone: [email protected]
Industries & Categories
Biopharma, Biotechnology, Genetics, Life Science, Medical
Social Profiles
Canonical: https://fsome.com/organization/egenesis-112651 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.